tiprankstipranks
Adial Pharmaceuticals Inc (ADIL)
NASDAQ:ADIL
US Market
ADIL
Adial Pharmaceuticals
RESEARCH TOOLSreports
Want to see ADIL full AI Analyst Report?

Adial Pharmaceuticals (ADIL) Income Statement

606 Followers

Adial Pharmaceuticals Income Statement

Last quarter (Q4 2025), Adial Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Adial Pharmaceuticals's net income was $-2.00M. See Adial Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Mar 24Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -565.00$ 0.00$ -564.00$ 0.00$ 0.00
Operating Expenses
$ 7.80M$ 8.28M$ 6.89M$ 10.86M$ 19.29M
Depreciation and Amortization
$ 565.00$ 565.00$ 564.00$ 564.00$ 55.11K
EBITDA
$ -7.80M$ -8.28M$ -7.00M$ -10.86M$ -17.69M
Operating Income
$ -7.80M$ -8.28M$ -6.89M$ -10.86M$ -19.29M
Other Income/Expenses
$ -177.71K$ -4.91M$ -113.94K$ 63.34K$ -228.68K
Pretax Income
$ -7.98M$ -13.20M$ -7.00M$ -10.80M$ -19.52M
Net Income
$ -7.98M$ -13.20M$ -7.00M$ -12.73M$ -19.42M
Per Share Metrics
Basic EPS
$ -11.93$ -17.75$ -136.00$ -299.50$ -653.00
Diluted EPS
$ -11.93$ -17.75$ -136.00$ -299.50$ -653.00
Weighted Average Shares Outstanding
 668.63K 743.55K 56.99K 42.52K 29.74K
Weighted Average Shares Outstanding (Diluted)
 668.63K 743.55K 56.99K 42.52K 29.74K
Currency in USD

Adial Pharmaceuticals Earnings and Revenue History